GSP在药品批发企业不合格药品管理中的作用  

The role of GSP in the management of unqualified medicine in pharmaceutical wholesale enterprises

作　　者：周碧雯 ZHOU Biwen(Sinopharm Group Co.,Ltd.,Shanghai 200051,China)

机构地区：[1]国药控股股份有限公司,上海200051

出　　处：《上海医药》2020年第19期65-69,共5页Shanghai Medical & Pharmaceutical Journal

摘　　要：目的:分析GSP在药品批发企业不合格药品管理中的作用。方法:从不合格药品的界定入手,结合GSP及自身管理实践,阐述如何规范不合格药品管理,并论述规范不合格药品管理与企业经营效率和经济效益的关系。结果:GSP不仅能规范不合格药品的管理,还能提升企业经营效率和经济效益。结论:合理应用GSP及其内嵌的质量管理理论及方法,不仅使企业经营风险降低,还能实现企业在新《药品管理法》监管下的社会责任与担当。Objective:To Analyze the role of GSP in the management of unqualified drugs in pharmaceutical wholesale enterprises.Methods:Starting with the definition of unqualified drugs and combining with GSP and own management practice,this article expounds how to regulate the management of unqualified drugs and discusses the relationship between the standardization of the management of unqualified drugs and the business efficiency and economic benefits of enterprises.Results:GSP can not only standardize the management of unqualified drugs,but also improve the business efficiency and economic benefits of enterprises.Conclusion:The rational application of GSP and its embedded quality management theories and methods will not only reduce the business risks of enterprises but also realize the social responsibility of enterprises under the supervision of the new Drug Administration Law.

关 键 词：药品经营质量管理规范 药品批发企业 不合格药品 药品管理法 

分 类 号：R954[医药卫生—药学]